MedicaidCoverageLow impact
Age Restriction Update for Beremagene Geperpavec-Svdt (Vyjuvek) Procedure Code J3401
Texas Medicaid·TX · Dermatology, Pediatrics·Coding
Effective date
Mar 1, 2026
We identified it
Jan 24, 2026
Summary
Effective March 1, 2026, the FDA has approved age expansion for beremagene geperpavec-svdt (Vyjuvek) procedure code J3401 to include adult and pediatric clients of all ages, removing previous age restrictions. This change applies to Texas Medicaid and managed care organizations must provide this medically necessary service to enrolled members.
Action Required
Before March 1, 2026: Billing team must update system settings to remove age restrictions for HCPCS code J3401 (beremagene geperpavec-svdt/Vyjuvek). Contact specific Texas Medicaid MCOs to verify any administrative requirements like prior authorization or referrals, as these may vary by plan. Update encounter forms to reflect expanded age eligibility.